IR@PKUHSC  > 北京大学第一临床医学院  > 皮肤性病科
学科主题临床医学
Gangliocytic paraganglioma: a multi-institutional retrospective study in Japan
Okubo, Yoichiro1; Nemoto, Tetsuo1; Wakayama, Megumi1; Tochigi, Naobumi1; Shinozaki, Minoru1; Ishiwatari, Takao1; Aki, Kyoko1; Tsuchiya, Masaru2; Aoyama, Hajime3; Katsura, Kanade4; Fujii, Takeshi5,6; Nishigami, Takashi; Yokose, Tomoyuki7; Ohkura, Yasuo8; Shibuya, Kazutoshi1,9
关键词Gangliocytic paraganglioma Neuroendocrine tumor Progesterone receptor Pancreatic polypeptide
刊名BMC CANCER
2015-04-12
DOI10.1186/s12885-015-1308-8
15
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
资助者Health Science Research Grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan ; Strategic Basis on Research Grounds ; Strategic Research Foundation ; KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ; Toho University project grants ; Yokohama Foundation ; Toho University Medical School ; Kurozumi Medical Foundation ; Health Science Research Grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan ; Strategic Basis on Research Grounds ; Strategic Research Foundation ; KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ; Toho University project grants ; Yokohama Foundation ; Toho University Medical School ; Kurozumi Medical Foundation
研究领域[WOS]Oncology
关键词[WOS]OF-THE-LITERATURE ; RARE CASE-REPORT ; NEUROENDOCRINE TUMORS ; METASTASES ; DUODENUM
英文摘要

Background: Gangliocytic paraganglioma (GP) is an extremely rare benign tumor that commonly arises from the second part of the duodenum. Since GP exhibit neither prominent mitotic activity nor Ki-67 immunoreactivity, this tumor is often misdiagnosed as neuroendocrine tumor (NET) G1 (carcinoid tumor). However, patients with GP may have a better prognosis than patients with NET G1. This fact emphasizes the importance of differentiating GP from NET G1, but few studies have reported the epidemiology and histopathology of GP because of its rarity. To differentiate GP from NET G1 with ease, we conducted a multi-institutional retrospective study analyzing the morphometric and immunohistochemical features of this tumor.

Methods: Since only a limited number of patients with GP could be identified in our institute, we conducted a multi-institutional retrospective study of GP in Japan, which was approved by the Ethics Committee of our medical institute. The obtained tissue sections underwent detailed morphometric and immunohistochemical analyses. Additionally, to differentiate GP from NET G1 with ease, immunohistochemical findings were compared.

Results: In our examination of 12 cases of duodenal GP, we found that epithelioid cells of GP exhibited positive reactivity for progesterone receptor and pancreatic polypeptide, whereas tumor cells of NET G1 were completely negative reactivity for both. Additionally, although GP is considered to be an extremely rare NET, we found that four (40.0%) of the ten patients at our institute with duodenal NET G1 actually had GP.

Conclusions: Although GP is regarded as a rare NET, our results suggest that it accounts for a substantial percentage of duodenal NETs. Additionally, confirmation of immunoreactivity for progesterone receptor and pancreatic polypeptide can assist in differentiating GP from NET G1.

语种英语
所属项目编号H25-Shinkou-Ippan-006 ; H26-shinkou-Jitsuyouka-Ippan-010 ; 24790364 ; 26860250 ; 26460460 ; 26860774 ; 23-19 ; 23-21 ; 23-28 ; 24-11 ; 24-16 ; 24-27 ; 24-28 ; 25-33
资助者Health Science Research Grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan ; Strategic Basis on Research Grounds ; Strategic Research Foundation ; KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ; Toho University project grants ; Yokohama Foundation ; Toho University Medical School ; Kurozumi Medical Foundation ; Health Science Research Grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan ; Strategic Basis on Research Grounds ; Strategic Research Foundation ; KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ; Toho University project grants ; Yokohama Foundation ; Toho University Medical School ; Kurozumi Medical Foundation
WOS记录号WOS:000352840100001
引用统计
被引频次:14[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62180
专题北京大学第一临床医学院_皮肤性病科
作者单位1.Toho Univ, Sch Med, Dept Surg Pathol, Ota Ku, Tokyo 1438541, Japan
2.Univ Ryukyus, Dept Pathol & Oncol, Okinawa 9030214, Japan
3.Toranomon Gen Hosp, Dept Pathol, Minato Ku, Tokyo 1058470, Japan
4.Steel Mem Hirohata Hosp, Dept Pathol, Himeji, Hyogo 6711122, Japan
5.Kyorin Univ, Sch Med, Dept Pathol, Mitaka, Tokyo 1818611, Japan
6.Toho Univ, Sch Med, Dept Surg Omori, Div Gen & Gastroenterol Surg,Ota Ku, Tokyo 1438541, Japan
7.Japanese Red Cross Kyoto Daini Hosp, Dept Pathol, Jokyo Ku, Kyoto 6028026, Japan
8.Kanagawa Canc Ctr, Dept Pathol, Asahi Ku, Yokohama, Kanagawa 2450815, Japan
9.Peking Univ, Hosp 1, Dept Dermatol, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Okubo, Yoichiro,Nemoto, Tetsuo,Wakayama, Megumi,et al. Gangliocytic paraganglioma: a multi-institutional retrospective study in Japan[J]. BMC CANCER,2015,15.
APA Okubo, Yoichiro.,Nemoto, Tetsuo.,Wakayama, Megumi.,Tochigi, Naobumi.,Shinozaki, Minoru.,...&Shibuya, Kazutoshi.(2015).Gangliocytic paraganglioma: a multi-institutional retrospective study in Japan.BMC CANCER,15.
MLA Okubo, Yoichiro,et al."Gangliocytic paraganglioma: a multi-institutional retrospective study in Japan".BMC CANCER 15(2015).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Okubo, Yoichiro]的文章
[Nemoto, Tetsuo]的文章
[Wakayama, Megumi]的文章
百度学术
百度学术中相似的文章
[Okubo, Yoichiro]的文章
[Nemoto, Tetsuo]的文章
[Wakayama, Megumi]的文章
必应学术
必应学术中相似的文章
[Okubo, Yoichiro]的文章
[Nemoto, Tetsuo]的文章
[Wakayama, Megumi]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。